| abstract |
PROBLEM TO BE SOLVED: To be therapeutically effective in treating airway channels such as asthma and pulmonary diseases, and to have low bioavailability and low systemic side effects when administered by intranasal administration or oral inhalation. Providing corticosteroids that exhibit An aerosolized medicament for the initial treatment or maintenance of asthma by taking once a day by oral inhalation, comprising mometasone furoate and having a systemic level of mometasone in the bloodstream An aerosolized drug that is substantially free of furoate. [Selection figure] None |